Professor A S Parkes (London)
The Biology of the Reproductive Hormones
The anterior pituitary body is usually regarded as the focal point of the endocrine system because it produces the trophic hormones which activate the ovary and thyroid, adrenal and mammary glands and is in turn regulated by humoral or neurohumoral feed-back mechanisms from these glands and the female reproductive tract. This system, as far as it relates to the reproductive organs and adrenal cortex, is shown in Fig 1, which is selfexplanatory subject to the following notes:
(1) The effect of the ovary on the adrenal is seen only where there is sex dimorphism or cyclic changes in the adrenal. In the same way, the production of gonadal-like hormones by the adrenal with consequent effects on the accessory reproductive organs becomes manifest only under abnormal circumstances. The important systemic effects of the adrenal-cortical hormones need not be considered here.
(2) Events in the female reproductive tract influence the ovary by reflex stimulation of the hypothalamus and thence of the adenohypophysis. Thus, mating is necessary for the induction of ovulation in the rabbit and the ferret, and in the rat and mouse for the stimulation of the corpus luteum of ovulation required to interrupt the five-day oestrous cycle and permit implantation of the fertilized egg (sterile mating is followed by a pseudopregnancy which lasts twice as long as the usual di-aestrous interval in the unmated female). In other species implantation of the fertilized egg, or possibly even the presence of a fertilized egg in the reproductive tract, results in maintenance of the corpus luteum which would otherwise undergo regression. In some species tight timing is implied. Thus, in man, the fertilized egg becomes implanted only a very few days before the corpus luteum would otherwise begin to hypotrophy preparatory to the next menstrual period.
(3) The presence of high levels of cestrogen or progesterone in the body reduces the secretion of FSH and LH, presumably through the mediation of the hypothalamus, so that overstimulation of the ovary is prevented. In the same way production of milk by the mammary gland in excess of demand causes reflex inhibition of prolactin secretion, whereas a strong suckling stimulus applied to the nipple stimulates the secretion of prolactin.
Fig 1 Endocrine and neurohumoral interactions concerned in reproduction
Ad, adrenal cortex. AH, adenohypophysis. HT, hypothalamus. MG, mammary gland. OF, ovarian follicle. CL, corpus luteum. FSH, follicle stimulating hormone. LH, luteinizing hormone. LTH, luteotrophin (prolactin). 0, £Estrogen. P, progesterone.
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-Neurohumoral effects concerned in regulating the adenohypophysis through the hypothalamus. .Ovarian hormone feed-back mechanism !o the adenohypophysis (4) The hypothalamus and thence the adenohypophysis and the reproductive organs are affected by exteroceptive factors such as light, so that the ancestrous ferret, for instance, can be brought into cstrus during the winter by exposure to artificial light during the evenings. This outline of the endocrine effects concerned in regulating the reproductive cycle shows a complex and delicately-balanced system and the surprising thing is not that there is sometimes a breakdown but that breakdowns are not more frequent.
A remarkable extension of our knowledge of exteroceptive factors influencing the reproductive processes arises from the work of Bruce (1959) , who has shown that pregnancy is blocked in a large proportion of newly-mated female mice exposed to the smell of males of a different strain. The immediate cause of the block is failure of implantation, which can be corrected by the administration of exogenous prolactin and presumably depends therefore on olfactory inhibition of luteotrophin secretion and consequent corpus luteum failure. The nature and source of the odour producing this effect is unknown, but it evidently belongs to the group of substances now attracting much attention, namely, substances which are not concerned as hormones with the integration of the individual but are concerned with the integration of a population of individuals. Karlson & Butenandt (1959) have coined the name 'pheromones' for these substances, which include the sex attractants of moths and the recently isolated and synthesized queen-bee substance, and we are evidently seeing the birth not of a branch of endocrinology but of the science of exocrinology.
Dr Margaret Hadley Jackson (Exeter)
Observations on the Use of Certain Orally Active
Progestogens for the Control of Fertility in Women
The story of the detection and isolation of the steroid hormones, and oftheir synthesis and modification by ingenious chemical and physiochemical techniques is an excellent example of the extreme value of close collaboration between scientists and commercial firms. Fundamentally it was the insight of such scientists as Zondek and Laqueur that initiated collaboration of this sort. It is difficult to visualize the immense amount of work, ingenuity and money that goes into the marketing of a new product. Dozens, and in some cases hundreds, of possible compounds are synthesized and discarded for one that may be useful.
The orally active progestogens originated from this kind of laborious and at times unrewarding work. Every new compound has to be screened for its range of therapeutic effectiveness, its toxicity and general acceptability. These synthesized steroids, no less than the natural hormones, possess a wide range of biological activities some of which are not only unnecessary but may even be undesirable in a particular therapeutic application. There is therefore a need for what Hartley (1957) has so neatly called 'tailored steroids'. There have already been considerable advances in that direction; the observation, for example, that removal of the methyl group at position 19, or the addition of one at position 6, makes for greater progestogenic activity opened up wide therapeutic fields. Although these progestogens started life as agents for aiding fertility by their action on the endometrium they are now being successfully used to limit fertility by inhibiting ovulation. This property is shared by other steroids, notably the androgens and aestrogens, but both these hormones produce other effects which are undesirable in the control of fertility.
Besides the above-mentioned progestational effect on the endometrium and the inhibition of ovulation, the progestogens have a number of actions which are exhibited in varying degrees by the different compounds. They have anabolic and fluid retaining properties; some androgenic, myotrophic and thermogenic activity; mild corticoid and cestrogenic activity; gonadotrophin inhibitory and anti-aestrogenic effects; influence on water and electrolyte excretion and on mating behaviour. All these activities must be assessed first by laboratory screening tests and later by careful clinical trials before a compound is offered for clinical use.
Previous Clinical Trials
Much of the early clinical work with oral progestogens was planned and carried out in the United States of America by Pincus and Rock, at first with a view to enhancing fertility but later as a contraceptive measure (Pincus 1958; Pincus, Rock & Garcia 1958 Pincus, Rock, Chang & Garcia 1959; Rock et al. 1956; Rock et al. 1957 Rock et al. , 1959 . Of a large number of progestational compounds tried, the most promising were norethynodrell and norethisterone.2 Extensive trials 5Norethynodrel = 17a-ethinyl -17-hydroxy-5 (10)-aestren-3-one. This is available in Britain as Enavid (Searle) in 5 mg and 10 mg tablets containing 0 075 mg and 1-5 mg ethinylcestradiol 3-methyl ether, respectively. The 5 mg tablet is also marketed specifically for oral contraception as Conovid. Enovid (Searle) is the name of the American preparation.
'Norethisterone= 17a-ethinyl-17-hydroxy-19 -Nor-4-androsten-3-one= 17-ethinyl-19-nortestosterone. This is available in Britain as Primolut N (Schering A.G.) and in the United States as Norlutin (Parke Davis). have been made of both these compounds. The results of those in Puerto Rico and Haiti, which were started in 1956 by Pincus (see Garcia et al. 1958) , and in Los Angeles by Tyler (Tyler 1959 , Tyler & Olson 1959 are well known. From these trials and others in Mexico a considerable mass of clinical evidence is accumulating on the other side of the Atlantic.
Trials are also running in Europe, Australia and Japan but the number of patients treated is small and little has been published. A trial carried out in Belgium with norethisterone acetate' was described by Peeters et al. (1960) . The ovulation inhibitory action of the Italian preparation Farlutal2 has been described (Goisis & Cavalli 1959 ) but its trial as a contraceptive agent has not been reported. In this country small, carefully controlled, trials of norethynodrel, norethisterone and norethisterone acetate have been in progress for nearly two years; larger clinical trials have recently been set up in Birmingham and Slough, both with norethynodrel. Another is to be started shortly under the auspices of the Council for the Investigation of Fertility Control and run from the Family Planning Association headquarters using norethisterone with added cestrogen. Two orally active progestogens produced by British Drug Houses have had preliminary clinical screening and are almost ready for trial as oral contraceptives.These are not 'nor' preparations but have an added methyl group at 6; one is similar to Farlutal (Farmitalia) and Provera (Upjohn).
Among other available progestogens, norethandrolone (17-ethyl-19 nortestosterone, Nilevar, Searle) was rejected as an oral contraceptive because of its marked anabolic effect; methylcestrenolone (Orgastrone, Organon) for its androgenic effects; allylcestrenol (Gestanin, Organon) and dimethisterone (Secrosteron, B.D.H.) because they had little ovulation inhibitory activity.
A good deal is already known about the shortterm effects of these progestogens in women, and a little about their effect in men (Heller et al. 1958 , Nelson 1959 , but it will be many years before a complete answer can be given as to their possible long-term effects. There is so far no evidence that prolonged administration ofprogestogens is harmful and in particular there is no evidence that they are carcinogenic. (Estrogens, on the other hand, are known to be potential carcinogens, but these are used in only very small amounts in oral contraceptives and although administration is pro-1Norethisterone acetate = 17,B-acetoxy-17 aethinyl-astr.4-en-3-one. This is not generally available in this country but is being used in clinical trial as S.H. 639 (Schering A.G.). It is available in the United States as Norlutin A (Parke Davis).
'6a-methyl-17a-hydroxyprogesterone acetate. longed, it is not continuous; there is a break in the tablet-taking at regular intervals so that there may be a withdrawal bleeding. Most investigators in charge of clinical trials have concluded that it is desirable to incorporate a very small dose of oestrogen with the progestogen in order to maintain the integrity of the endometrium, to prevent 'spotting' (break-through bleeding) and to keep the cycles regular; but since there is some conflicting evidence on this point, the use of a progestogen alone cannot be excluded.
Personal Observations
These are based on clinical trials ofnorethynodrel, norethisterone and norethisterone acetate. Women, all multiparous, many of them problem patients with big families, some with severe menorrhagia, have been allocated at random to two main groups, one to receive norethynodrel, the other equally divided into the recipients of two norethisterone preparations. The first tablets were distributed in March 1959 and the groups have been built up gradually since then so as to contain between 25 and 30 patients in each and are now being kept at that figure by adding fresh entrants as and when previous participants fall out. Out of 32 entrants to the first group there are' 25 current cases and in the second there are now 12 in each sub-group out of 16 and 15 entrants respectively. Dosage ofNorethynodrel 5 mg tablets (containing 0-075 mg cestrogen) 2 5 mg tablets (containing 0'15 mg cestrogen) 2 5 mg tablets (containing 0 10 mg cestrogen) The aestrogen used in the norethynodrel tablets which have been supplied by Searle, is ethinylcestradiol-3-methyl-ether. Of those that were started on the 5 mg tablets the majority have had their dosage cut to 2-5 mg. A few that started on 2 5 mg have later been given 5 mg tablets. The adjustment of the dose (in particular in the amount of cestrogen) to avoid minor troubles such as breast discomfort and 'spotting' is a highly individual affair and needs a little dexterity on the part of the doctor. I am hoping that the use of the vaginal smear technique will make the choice of the correct dose and drug easier to arrive at.
Dosage ofNorethisterone
Norethisterone 5 mg Norethisterone 2 5 mg Norethisterone acetate 4 mg Norethisterone acetate 2 mg All preparations of norethisterone and its acetates have been supplied by Schering and contain no added cestrogen. All subjects receiving norethisterone have been started on 5 mg and only a few have been reduced to 2 5 mg. The acetate has been given in 2 mg strength in about half the cases from the start.
Instructions and Records
Each patient is given written instructions and a card on which to record bleeding and 'spotting', intercourse and the taking of tablets. Weight and blood pressure readings are recorded at intervals and notes are kept of symptoms and general comments.
Side-effects and Results
Side-effects have not been troublesome in either group and no one, up to the time of writing, has withdrawn from the trial because of them. In all cases the dose has been adjusted (usually in a downward direction) if the patient has suffered any sideeffects. Gastrointestinal symptoms and breast discomfort are commoner with norethynodrel; whereas a bloated feeling, slight weight gain and hunger, headaches and irregularities of cycles (including breakthrough at short intervals and no bleeding at the end of the twenty days on tablets) are more often met in patients on norethisterone and norethisterone acetate. I have no doubt that this rather troublesome irregularity could be largely avoided by addingoestrogen but I have purposely avoided doing this in order to learn how well patients would tolerate this degree ofirregularity and whether with persistence a more regular rhythm would become established. Provided a woman can be persuaded that she need not worry if a bleeding does not appear she will usually become adjusted to irregularity and in the majority of cases the cycles do tend to get more regular with time. Libido has shown little change and most of the patients feel well while taking the tablets; the few who have felt vaguely unwell have been taking one of the norethisterone preparations. No one has conceived while taking the tablets correctly; three took their tablets wrongly and conceived forthwith (2 in the Searle and 1 in the Schering group). Three havewithdrawn, one because she no longer needed birth control, one because she was frightened by what she had read in the papers and one because she had a serious motor accident. There have been no instances of masculinization, gross cedema or consistent rise in blood pressure.
Basal temperature charts have been kept by the majority of patients and they tend to be quite erratic, particularly in the norethynodrel group. With the norethisterone preparations a rise within twenty-four hours of the first tablet is not infrequently seen.
Post-coital examination of cervical mucus is carried out whenever possible; about 40 such examinations have been made. In the norethynodrel group nearly 50% show motile sperm and the mucus tends to be moderately plentiful and quite elastic at any point in the cycle; whereas in the norethisterone group (on pure progestogens) the mucus is scanty and tenacious, and if sperm are present, they are invariably immotile.
Vaginal smears, stained with a modification of the Papanicolaou technique, are being studied. The work is not yet far enough advanced to be worth reporting.
Endometrium for biopsy is collected from all patients at various points in the cycle. The tendency is towards atrophy which may develop rapidly or quite slowly; in some a mixed picture is produced; the fibrillar type of stroma is seen more commonly in patients on the norethisterone preparations than in those on norethynodrel. It was noted that in the latter group of patients the endometrium can become just as atrophic as in those on norethisterone in spite of the added cestrogen; indeed, the woman (aged 32 and para-5) with the most marked and persistent degree of atrophy has been on norethynodrel tablets which contain cestrogen. Before starting to take the tablets she was menorrhagic with a hyperplastic endometrium. The character of the changes in the histological picture is somewhat different in the two groups:
In the norethynodrel cases up to cycle day nineteen (i.e. after fifteen days on tablets) subnuclear vacuolation may be found in a few glands and it appears very soon after the first 2 or 3 tablets have been taken (i.e. by the seventh or eighth day of the cycle). It seems to be most marked on cycle days sixteen and seventeen (i.e. after twelve or thirteen days on tablets). Towards the end of the twenty days on tablets the glands tend to become small and atrophic, the cells having lost height and substance and their nuclei being pyknotic. The stroma may be loose and cedematous or dense and cellular showing the characteristic fibrillar change; towards the end of the cycle there may be patches of quite marked decidual response but where the endometrium becomes really atrophic, none of these changes can be seen.
In the cases on norethisterones (which contain no added aestrogen) subnuclear vacuolation does not appear at any point in the cycle and the glands remain small and uncoiled but the nuclei do tend to line up near the basement endometrium. The stroma in these cases is mostly densely cellular from an early stage with the characteristic fibrillar appearance; it may show decidual change later but the individual cells and nuclei are smaller and stain more darkly than in normal late secretory endometrium or in the norethynodrel cases.
The British Drug Houses experimental tablets, 1298 and 1921, have so far only been subjected to clinical screening. Three tests have been used: (a) Postponement of menstruation (with and without estrogen) as suggested by Greenblatt et al. (1958) and Swyer et al. (1960) ; this cannot be achieved with either drug with doses up to 20 mg daily unless the progestogen is combined with a small dose of cestrogen. (b) The building of secretory endometrium after cestrogen priming in a previously atrophic endometrium. A good secretory endometrium can be built in one previously atrophic after initial priming with cestrogen in response to both products in doses of 10 and 5 mg daily, given from cycle day sixteen or seventeen. (c) Inhibition of ovulation, with and without cestrogen. There is some evidence that both drugs will inhibit ovulation in doses of 10 and 5 mg daily, providedthe tablets are given from cycle day five, say, onwards. Both have a marked thermogenic effect, the rise occurring within twenty-four hours of the first dose. Side-effects have been variable, some patients complaining of little or nothing; others felt tired and listless and a few felt bloated with premenstrual tension and headache. There has been no indication of any androgenic effect. In contrast with experiments in the human, experiments on the use of hormones to control fertility in farm animals are almost invariably concerned with efforts to increase fertility. Only a brief summary can be given here of the more recent contributions in this field, including some from our own laboratory.
The control of reproductive activity in intensively managed farm stock is a delicately balanced self-compensating mechanism which may get out of phase. Reproductive activity does not always respond to exogenous preparations as we anticipate, and there may be wide variations in response between animals and between experiments. We know too little about the endocrine control of reproduction in farm animals to achieve quick results from ad hoc field trials. Ample evidence is also available from many experiments that species differences in response to standard hormone preparations preclude the application of the results from experiments in one species to other classes of animals.
The various purposes for which hormones are used to control reproduction are discussed under the following headings: (1) Control of the cestrous cycle during the normal breeding season.
(2) Increase of the ovulation rate by the use of gonadotrophins. 
Control of the (Estrous Cycle During the Normal Breeding Season
Ancestrus is particularly common in cattle and pigs when they are managed intensively, or where nutritional deficiencies (ofboth macro-and micronutrients) create a metabolic disturbance. In the three major classes of farm stock heavy lactation militates against reproductive activity especially where the young are suckled. Steroid sex hormones, particularly the synthetic aestrogen, diethyl stilbcestrol, will induce oestrus but this is not usually accompanied by ovulation. One successful form of treatment in cows, when the ancestrus is caused solely by a persistent corpus luteum, is its manual removal from the ovary per rectum; a fertile heat usually occurs two to four days after such treatment provided the conditioft is not accompanied by pyometritis. In cases of spontaneous ancestrus the injection of pregnant mare's serum (P.M.S.) gonadotrophin to stimulate developme-nt of the ovaries has proved of limited value for there is a wide variation in response. The ovarian follicular response to P.M.S. is improved if there is a corpus luteum in the ovary and although ovulation may occur if luteinizing hormone is injected it is not accompanied by behavioural cestrus and fertilization does not result even following artificial insemination (Rowson 1951) .
In ancestrous cattle, rectal palpation has been shown to stimulate spontaneous activity of the reproductive tract. It has also been suggested that irrigation of the bovine uterus may cause the release of gonadotrophic hormones (Hancock 1948 , Smythe 1943 , and rectal palpation of the cervix or uterus results in the release of oxytocin as shown by uterine contractions and milk ejection (Hays & VanDemark 1953) . Electrical stimulation may be a more practical way of stimulating resumption of activity. Hays & Carlevaro (1959) have stimulated the area of the ovaries, uterus and cervix of cows using 10-15 volts for two seconds. They observed the animals for cestrous behaviour for seven days following treatment. There was no effect in cows treated within fifty days post partum but beyond fifty days and in anoestrous cows, cestrus was produced in approximately 50% of animals treated; it occurred spontaneously in only 5 % of untreated controls. The authors suggested that the stimulation resulted in the release of oxytocin which then affected the release of gonadotrophins from the anterior pituitary gland. Armstrong & Hansel (1958) also postulated that in the cow oxytocin is associated with the release of gonadotrophin, for normal cows given oxytocin daily from the day of oestrus for eight days came into cestrus one to four days after treatment ceased. When daily injections were begun on the fifteenth day the heifers came into cestrus at the normal time. When these injections were continued to seven days post-oestrus, the animals again came into cstrus soon after treatment ceased. All animals ovulated normally after the induced cestrus. The effects of these treatments require further study.
The availability of forms of progesterone which are active orally has resulted in a new approach to the synchronization ofcestrous cycles ofanimals which are breeding normally. The injection of progesterone intramuscularly has been used by Rowson and his colleagues (Hunter 1953 , Hunter et al. 1955 to synchronize aestrus in donor and receptor sheep used for egg transplantation, but such a method is too complicated for large-scale practical application. The orally-active form 6a-methyl-1 7a-hydroxy progesterone acetate (Provera, Upjohn) has been used experimentally to synchronize cestrus in beef cattle. From the limited results available so far, it will synchronize the cycle, oestrus occurring approximately three to four days after dosing ceases (Hansel 1961, personal communication) . It is not yet known whether normal levels of fertility may be expected following such treatment. If this method proves successful it could have wide practical application, especially in countries with large beef herds, where many thousands of cattle could be inseminated from valuable bulls by a limited number of technicians. At the present time artificial insemination under such conditions is not practised because of the technical difficulties involved.
Increase of the Ovulation Rate by the Use of Gonadotrophins
The availability of an inexpensive form of gonadotrophin in the form of pregnant mare's serum (P.M.S.) resulted in an interest in experiments to increase ovulation rate particularly in sheep and beef cattle, in order to obtain a high proportion of twins.
In sheep, the injection of a single dose ofP.M.S. during the follicular phase of the aestrous cycle can increase ovulation rate, the actual number of eggs shed being influenced by dose rate. Gordon (1958) has completed extensive field trials with sheep using methods developed by Robinson (1951a, b) . His experiments showed that treatment resulted in a significant increase in fertility, the extent depending on the level of dose given, and the greatest increase occurred in flocks of low fertility. There was no evidence that the treatment affected the ability of the ewe to conceive. High dose rates (1,000 i.u.) were not advocated because of the number of quadruplets and quintuplets born which had a higher incidence of neonatal mortality. Gordon (1961, personal communication) has extended his work to further study on the use of P.M.S. in beef cattle and the results of his trials in the Welsh Border district are now becoming available. The cows were injected about the sixteenth or seventeenth day of the twenty-oneday cestrous cycle. Of 356 cows treated 37 4 % responded with multiple ovulation. One major problem was that treatment increased the incidence of 'silent heat' (ovulation without behavioural cestrus). Of the treated cattle 14-8% had 'silent heats' and this occurred more frequently where cattle were injected late in the cycle. Of those which were inseminated conception rate appeared normal but there was a higher incidence of embryonic loss in treated cattle which ovulated two or more eggs, especially when ovulation was unilateral.
Before further commercial application in cattle is warranted there is need for study on the factors affecting the response to P.M.S. and why embryonic mortality is higher after multiple ovulation in cattle but not abnormally so in sheep treated with low doses of P.M.S. In sheep, treatment with P.M.S. is more successful, but the technique should be used only after taking full advantage of good management to increase the ovulation rate.
Overcoming Seasonal Antzstrus While some breeds of sheep are polycestrous the majority of breeds in Britain show a period of quiescence or seasonal ancestrus during summer. This may be preceded in breeding ewes by lactation anoestrus so that under normal conditions animals breed only once per year, a factor which limits the utility of sheep in intensive systems. Seasonal anoestrus is characterized by suppressed cycles of follicular development with occasional ovulation, and the occurrence of an annual rhythm of reproductive activity is under photoperiodic control. Experimental control of the diurnal light/dark ratio has been successfully used experimentally to bring sheep into cestrus (Sykes & Cole 1944 , Yeates 1949 , Hart 1950 , but the method is not practicable under farm conditions. Theories have been put forward to explain that in seasonal ancestrus there is probably a failure of the release of luteinizing hormone (L.H.) from the anterior pituitary gland (Kammlade et al. 1952 , Hutchinson & Robertson 1960 ) and this theory is compatible with observations of the hypothalamic control of anterior pituitary function (Harris 1955 , Clegg et al. 1958 . There is no clear explanation of the mechanism by which lactation suppresses cestrus in the ewe. The purpose of experiments described here is to use hormones to control the sexual activity of sheep during ancestrus. The response to alteration ofthe diurnal light/dark ratio is slow but uniform. The use of gonad stimulating preparations (anterior pituitary preparations, human chorionic gonadotrophin, and P.M.S.) usually induces ovulation without heat. If a second injection of P.M.S. is given sixteen to seventeen days after the first injection aestrus may occur, but the degree of response is not uniform and the incidence of behavioural cestrus is low. Recent work has shown that progesterone and (estrogen act synergistically on the nervous system particularly in the production of psychic cestrus (Moore & Robinson 1957 ). Therefore to induce a higher incidence of behavioural cestrus in sheep accompanied by ovulation, attention has now been turned to the subcutaneous injection of P.M.S. preceded by a series of progesterone injections given intramuscularly. Dutt (1952 Dutt ( , 1953 and Robinson (1954) were successful in obtaining cestrus, ovulation and fertility in non-lactating sheep using spaced intramuscular injections of progesterone followed by subcutaneous P.M.S. More extensive field trials were carried out in England by Gordon (1957 Gordon ( , 1958 . The percentage of ewes responding varied from 32% to 90% in different flocks using various progesterone pre-treatments. The results of our own experiments in maiden sheep are largely similar (Table 1) . Even though aestrus can be induced in a proportion of lactating ewes, the conception rate of those which mate is low. There is no conclusive explanation for this; Gordon (1958) presumed that loss at implantation is responsible rather than failure of fertilization. This led us to compare the efficacy of changes in the light/dark ratio with hormone treatment. Table 1 The production of lambs from maiden ewes during the non-breeding season (Allen & Lamming 1959) In a group of 20 lactating ewes injections of progesterone and P.M.S. induced ovulation in 19 ewes and cestrus accompanied ovulation in 12 ewes. There was a complete failure of fertilization which could not be attributed to poor semen quality. Manipulation of the light/dark ratio induced ovulation in all 10 treated ewes and oestrus was observed in 9. Of the ova recovered from these sheep 41 % were cleaving normally. CEstrus was preceded by a 'silent heat'.
During treatment of ewes with progesterone and P.M.S., Raeside & Lamond (1956) found that the changes in the histology of the uterus occurring during progesterone pre-treatment were typical of the luteal phase of a normal oestrous cycle, but that the fallopian tubes which are quiescent during ancestrus did not develop their normal structure. We have completed chemical analysis of uterine secretions ofmaiden and lactating ewes treated with progesterone and P.M.S. approximately four to six weeks post partum (Heap 1960) . Our results show that the chemical composition of the secretion is changed by hormone treatment and the development of cyclic activity appears important (Heap & Lamming 1961, in preparation) . It would appear that the occurrence of a 'silent heat' at the beginning of Table 2 The production of lambs from lactating ewes during the non-breeding season the breeding season has a physiological significance for the level of fertility improves to a maximum at about the third cycle (Dutt 1954) , apparently as the result of a higher ovulation rate and a higher rate of fertilization with less abnormal ova and less embryonic mortality. The failure of fertilization in lactating ewes in our experiments does not appear to be due to the form of treatment per se since maiden ewes similarly treated in the same period conceived normally. Nor was it related to lactation per se for ewes strongly lactating after producing lambs in the autumn have normal conception rates seven to eight weeks post partum. Here again a 'silent heat' precedes such breeding activity.
In 1960 it was decided to compare the effect of two series of progesterone-P.M.S. injections with the standard treatment. The results are given in Table 2 . The double series of injections increased the incidence of aestrus, and increased the level of fertility but still did not result in normal numbers of lambs born. Better results were obtained in ewes from which the lambs were removed before treatment (Flocks 1 and 2). Where a limited number of additional lactating ewes have been examined under surgical anTsthesia following the second series of injections they have produced fertile ova two days post coitum. Further studies are in progress to determine whether the loss occurs before or after implantation.
In summary, hormone treatment can be used successfully to produce extra crops of lambs from maiden sheep during the non-breeding season at a reasonable cost. The optimum time for treatment appears to be as soon as possible after the close of the breeding season. Before the problem of breeding from lactating ewes can be solved, more experiments are required to explain the effect of lactation on fertility. Compounds are now available which have a progestational effect on the genital tract and a conditioning effect on the hypothalamus. Ethinyl-nor-testosterone (ethisterone) which is active orally may prove superior to progesterone for this purpose, for progesterone has to be injected regularly and is less effective in conditioning the hypothalamus. No reports have yet appeared on the use of 6a-methyl-17a-hydroxyprogesterone acetate in sheep.
Use of Steroid Hormones to Prevent Embryonic
Mortality Total or partial embryonic mortality is a serious loss in agriculture, especially because animals for meat are now killed at lower liveweights and, therefore, more young animals must be produced per breeding female to produce the same tonnage of meat. Reference to work in laboratory animals has proved illuminating but not particularly helpful because results cannot be readily transferred to farm species. D'Amour et al. (1933) noted that extracts of the corpus luteum given from day one to ten of pregnancy improved the conception rate in rats and that the pups were heavier at birth although litter size in the pregnant animals was not increased. Similarly, Nalbandov (1958) found that progesterone treatment did not affect litter size in rats, and Ulberg & Casida (1950) that the response of pregnant rabbits was very variable. In cattle of low fertility, cestrogen treatment has proved disadvantageous, but progesterone treatment improves the conception rate (Herrick 1953, Dawson 1954 , Wiltbank et al. 1956 , Johnson et al. 1958 .
Neither rats nor cattle, in contrast to pigs and possibly sheep, seem to be adversely affected by dose rates of progesterone considered in excess of physiological levels (Nalbandov 1958) .
Attempts to improve embryonic survival in pigs of normal fertility by the use of hormones have produced variable results. In some cases, particularly where high dose rates were used, the treatment appeared harmful to the growth and maintenance of the corpus luteum, especially if given during the first few days of pregnancy (Spies et al. 1959 ). However, improved embryonic survival has been reported during the first half of pregnancy in gilts when progesterone and aestrogen treatments have been combined (Reddy et al. 1958) . In sheep high dose rates appear detrimental to the growth of the corpus luteum (Zimbelman et al. 1959 ) but the long-term effect on the maintenance of pregnancy has not yet been determined.
Even if the above improvements in fertility of farm animals are confirmed there remains the question of the wide variation in response of animals to the treatment and the problem of developing satisfactory methods of application. Single injections may prove satisfactory where high dose rates are tolerated, particularly now that long-acting forms of progesterone are becoming available. In pigs and possibly in sheep, where high dose rates are not tolerated and where repeated injections are probably impracticable, orally active forms may prove to be of greater benefit.
Control of Uterine Infections
Endometritis is a most important cause of sterility of cattle, and persistent uterine infections with pyometritis are known to be associated with a persistent corpus luteum. The synthetic hormone, diethyl stilbcestrol, has been frequently used for treating the condition. Alternatively, the cestrous period which results after the manual removal of the corpus luteum per rectum acts as a mechanism similarly clearing the uterus of infection (Rowson et al. 1953) . It is known that conception rate improves if a heat period is allowed between parturition and insemination.
Susceptibility to many types of uterine infection in cattle is affected by ovarian hormones, the cow being resistant to experimental infections during cestrus but susceptible to infection when progesterone is being produced. We have compared the susceptibility of the cow, sheep, rabbit and rat to experimental uterine infections and found that both the cow and rabbit are susceptible when progesterone is active. On the other hand, the sheep appears relatively resistant to uterine infection at all stages of the cestrous cycle. The rat appears to have only moderate resistance to experimental uterine infections without significant differences during the cestrous cycle (Table 3 ). These species differences appear to be associated with the presence or absence of an acid-soluble fraction (A.S.F.), a carbohydrateprotein complex, of the uterine secretion. It is present at cestrus in the rat, during the luteal phase in the cow, during pseudopregnancy in the rabbit, but is absentper se in the sheep. When this material is present the uterus loses some of its resistance to experimental infections (Table 3) . The mechanism of this resistance has been studied in the species mentioned but most fully in the rabbit. The resistance or susceptibility to infection is largely related to changes in the activity of the granulocyte system. When cestrogen predominates (and when the A.S.F. is absent), granulocytes, particularly neutrophils, rapidly infiltrate into the infected uterus where they reduce the infection before the logarithmic phase of growth is reached. On the other hand, when progesterone is active in the rabbit, the rate of leucocyte infiltration into the uterus is reduced and those leucocytes which reach the endothelium are predominantly lymphocytes rather than granulocytes; experimental infections progress more rapidly and become established.
These observations offer an explanation of the benefit of synthetic and natural cestrogens in clearing uterine infections. The stimulation of natural defence mechanisms is probably associated with an increase in the number of locally available granulocytes and the absence of mechanisms which interfere with phagocytosis.
